Market Report, "Australia Pharmaceuticals & Healthcare Report Q4 2012", Published
BMI View: Australia will increasingly look towards price-containment policies as the rising burden of non-communicable diseases (associated with the increasingly ageing population) will escalate the government's expenditure on the Pharmaceutical Benefits Scheme (PBS). This is coupled with lacklustre growth in the economy. On the upside, eldercare providers (hospitals, medical devices suppliers and pharmaceutical firms) will see growth opportunities due to the ageing population. In addition, we note that generic drug suppliers will see further upside if the country promotes generic...
View full press release